Clinical Trials
55 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
PATHWAY
National Cancer Center, Japan
BIO-META
Consorzio Oncotech
Minnelide 101
Minneamrita Therapeutics LLC
EPOST MBC
University of Kansas Medical Center
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
OncoSec Medical Incorporated
REGOMUNE
Institut Bergonié
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
MULAN
Fudan University
A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer
Fudan University
SPACE2
Weprom
TONIC
The Netherlands Cancer Institute
X7-7
University of Kansas Medical Center
i-GO
UMC Utrecht
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
First Hospital of China Medical University
PIONEER
SpeciCare
CAMELLIA
ChineseAMS
Guided Imagery & Music in Cancer
Aalborg University
IMET
Federation of Breast Diseases Societies
FLIPPER
Spanish Breast Cancer Research Group
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Amsterdam UMC, location VUmc
COP-BREAST
Seoul National University Hospital
PALPETBIO
Assistance Publique - Hôpitaux de Paris
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included
Centro Hospitalar Lisboa Ocidental
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer
NeuroVita Clinic
Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
Unity Health Toronto
Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
Zhejiang Cancer Hospital
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
University of Kansas Medical Center
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Merrimack Pharmaceuticals
GIM11-BERGI
Consorzio Oncotech
Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies
Consorzio Oncotech
AMBRA
Consorzio Oncotech
FUMANCE
Consorzio Oncotech
FEVEX
Consorzio Oncotech
Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis
University of Zurich
Arbre
Jinling Hospital, China
Cultured Circulating Tumor Cells in Prostate and Other Cancers
Comprehensive Cancer Centers of Nevada
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer
National Cancer Institute (NCI)
Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
National Cancer Institute (NCI)
Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
ChineseAMS
Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
ChineseAMS
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Wales Cancer Trials Unit
METAMARBO
Universitaire Ziekenhuizen KU Leuven
Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)
ChineseAMS
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
University of Vermont
Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer
Croatian Cooperative Group for Clinical Research in Oncology
Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer
South Eastern European Research Oncology Group
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Sysmex America, Inc.
Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome
National Cancer Institute (NCI)